Molecular Basis of Differential Sensitivity of Myeloma Cells to Clinically Relevant Bolus Treatment with Bortezomib

Overview of attention for article published in PLOS ONE, February 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 69 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 50 publications that cite this research output.

50

The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.

Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2

Article in eLife (April 2024)

Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2

Article in eLife (April 2024)

Proteasome Inhibitors in Multiple Myeloma Biological Insights on Mechanisms of Action or Resistance Informed by Functional Genomics

Article in Hematology/Oncology Clinics of North America (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.